Digital Strategies for Medical Affairs

CyberThink in Action: 3 Digital Strategies for Medical Affairs

Everyone is talking about how Medical Affairs needs to evolve and innovate by being open-minded and future focused. But how? Below are the latest tips and trends in CyberThink—digital-first strategies that can be implemented today. CyberThink symbolizes a shift from traditional, siloed roles to a more integrated, technology-driven model where Medical Affairs is central to…...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...
Plain language summaries

3 Interesting Facts about Plain Language Summaries

Did you know these 3 facts about plain language summaries?...

World Patient Safety Day September 17, 2021 – Safe Maternal and Newborn Care

This World Patient Safety Day, let's make maternal and newborn care a global health priority...
Clinical Trial Pain Points

Pharma, Physician, and Patient Pain Points Regarding Clinical Trials

Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
FINAL Clinical Trial Summaries Blog-Banner-810x540

Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?

A majority of patients feel lay summaries for clinical trials are very important and won’t...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.